Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Metastatic Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06669572
What this trial is testing

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Who this might be right for
Carcinoma, Squamous CellAnorectal Cancer
University of Chicago 35
Not applicableNot Yet RecruitingNCT07781475
What this trial is testing

Spatially Fractionated Radiation Therapy for Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
The University of Hong Kong-Shenzhen Hospital 126
Large-scale testing (Phase 3)Study completedNCT01060501
What this trial is testing

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer

Who this might be right for
Rectal Cancer
University of Ulm 796
Early research (Phase 1)Study completedNCT04423029
What this trial is testing

DF6002 Alone and in Combination With Nivolumab

Who this might be right for
Solid Tumors
Dragonfly Therapeutics 170
Testing effectiveness (Phase 2)UnknownNCT03484195
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

Who this might be right for
Colonic NeoplasmsDrug Therapy
China Medical University, China 30
Not applicableUnknownNCT03042000
What this trial is testing

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT00941967
What this trial is testing

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 78
Testing effectiveness (Phase 2)Study completedNCT05459129
What this trial is testing

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Hoffmann-La Roche 12
Large-scale testing (Phase 3)Ended earlyNCT00085631
What this trial is testing

Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Mark Dewhirst 101
Not applicableNot Yet RecruitingNCT06722495
What this trial is testing

Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study

Who this might be right for
SBRTNeoadjuvant ImmunochemotherapyLA HNSCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 20
Not applicableLooking for participantsNCT06613165
What this trial is testing

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

Who this might be right for
Immune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer
Xijing Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04508829
What this trial is testing

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Who this might be right for
Oropharyngeal Carcinoma
Fudan University 52
Large-scale testing (Phase 3)Active Not RecruitingNCT01706939
What this trial is testing

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Who this might be right for
Squamous Cell Carcinomas
Icahn School of Medicine at Mount Sinai 23
Not applicableStudy completedNCT03645330
What this trial is testing

Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

Who this might be right for
Non-small-Cell Lung Cancer
Chugai Pharmaceutical 1,026
Testing effectiveness (Phase 2)Study completedNCT04799639
What this trial is testing

Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerChemotherapy EffectProgrammed Cell Death 1 Receptor / Antagonists & Inhibitors+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT04301557
What this trial is testing

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Who this might be right for
DMMR Colorectal CancerMSI-H Colorectal CancerLocally Advanced Colorectal Cancer
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Looking for participantsNCT04774419
What this trial is testing

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 62
Large-scale testing (Phase 3)UnknownNCT02957266
What this trial is testing

Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy

Who this might be right for
Cervical Cancer
The National Center of Oncology, Azerbaijan 400
Not applicableUnknownNCT05602831
What this trial is testing

Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
Fudan University 108
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Next Page